ITOC logo

iTonic Holdings Ltd. Stock Price

NasdaqCM:ITOC Community·US$7.0m Market Cap
  • 0 Narratives written by author
  • 1 Comments on narratives written by author
  • 7 Fair Values set on narratives written by author

ITOC Share Price Performance

US$0.39
-2.28 (-85.53%)
US$0.39
-2.28 (-85.53%)
Price US$0.39

ITOC Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Medium-low risk with mediocre balance sheet.

6 Risks
0 Rewards

iTonic Holdings Ltd. Key Details

US$305.2k

Revenue

US$52.3k

Cost of Revenue

US$252.9k

Gross Profit

US$2.7m

Other Expenses

-US$2.4m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
-0.14
82.86%
-790.57%
2.9%
View Full Analysis

About ITOC

Founded
1998
Employees
10
CEO
Jianfei Zhang
WebsiteView website
www.ftzy.com.cn

iTonic Holdings Ltd., a healthcare solutions provider, develops and commercializes treatment software and devices used for brachytherapy. Its proprietary treatment planning system is a radioactive particle implantation, a radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. The company offers FTTPS, a treatment planning system for treating various malignant tumors, which could determine the target volume, prescription dose, and dose limitation to protect organs at risks and produce dose distribution plan for brachytherapy for cancer patients. The company was formerly known as Pheton Holdings Ltd and changed its name to iTonic Holdings Ltd. in January 2026. iTonic Holdings Ltd. was founded in 1998 and is headquartered in Beijing, China. iTonic Holdings Ltd. operates as a subsidiary of ZJW (BVI) LTD.

Recent ITOC News & Updates

Recent updates

No updates